H. Monshizadegan

发表

The Guinea Pig as a Preclinical Model for Demonstrating the Efficacy and Safety of Statins

M. Blanar, M. Kowala, Rongan Zhang, 2008, Journal of Pharmacology and Experimental Therapeutics.

Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.

Natesan Murugesan, S. Chong, J. Barrish, 2002, Journal of medicinal chemistry.

Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics.

W. Humphreys, J. Macor, M. Kowala, 2005, Journal of medicinal chemistry.

Benzodiazepine-based selective inhibitors of mitochondrial F1F0 ATP hydrolase.

L. Hamann, P. Stein, D. Green, 2004, Bioorganic & medicinal chemistry letters.

Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity.

G. Grover, P. Sleph, D. Green, 2004, American journal of physiology. Heart and circulatory physiology.

Novel Peroxisome Proliferator-Activated Receptor α Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist

M. Blanar, Rongan Zhang, Jun Li, 2008, Journal of Pharmacology and Experimental Therapeutics.

Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective Agonist.

M. Blanar, Rongan Zhang, S. Krystek, 2016, ACS medicinal chemistry letters.

(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with reduced myotoxicity potential.

J. Barrish, M. Blanar, Rongan Zhang, 2008, Journal of medicinal chemistry.

Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for LDL Lowering

R. Parker, M. Witmer, Gerald, 2014 .

Expression of endothelin receptor subtypes in rabbit saphenous vein.

E. Liu, M. Webb, C. Chao, 1993, Molecular pharmacology.

Binding and signal transduction of the cloned vascular angiotensin II (AT1a) receptor cDNA stably expressed in Chinese hamster ovary cells

M. Webb, S. Moreland, K. Dickinson, 1993, Regulatory Peptides.

Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.

M. Webb, H. Monshizadegan, A. Hedberg, 1992, Life sciences.

Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells

E. Liu, M. Webb, S. Moreland, 1992, Peptides.

A switch in enantiomer preference between mitochondrial F1F0-ATPase chemotypes.

P. Stein, C. S. Madsen, H. Monshizadegan, 2005, Bioorganic & medicinal chemistry letters.

Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.

J. Macor, M. Kowala, M. Valentine, 2003, Bioorganic & medicinal chemistry letters.

Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.

E. Liu, M. Webb, R. Misra, 1993, The Journal of pharmacology and experimental therapeutics.

Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension

J. Barrish, J. Macor, M. Kowala, 2004, Journal of Pharmacology and Experimental Therapeutics.

Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).

Wei Wang, Jun Li, Ying Wang, 2010, Journal of medicinal chemistry.

Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering

Doree Sitkoff, Daniel Meyers, R. Parker, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Substrate specificity of human plasma lecithin-cholesterol acyltransferase towards molecular species of phosphatidylcholine in native plasma.

P. Subbaiah, H. Monshizadegan, 1988, Biochimica et biophysica acta.

Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation.

Daniel Meyers, Jonathan Lippy, Rongan Zhang, 2010, Bioorganic & medicinal chemistry letters.

The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta.

E. Liu, M. Webb, S. Moreland, 1992, Biochemical and biophysical research communications.

Role of endothelin receptor subtype B (ET-B) in myocardial ischemia.

E. Liu, M. Webb, G. Grover, 1994, Life sciences.

Thoromboxane A2/endoperoxide receptor antagonists: 1,3-Dioxane and 1,3-dioxolane analogs

M. Webb, J. Das, H. Monshizadegan, 1993 .